Safeguarding Women’s and Children’s Health Act of 2023

HR 2570 requires healthcare providers and manufacturers to report deaths or adverse events related to abortion drugs (like mifepristone) to the FDA within 15 days, using new online portals for secure, anonymous reporting. It mandates the CDC to collect and publish standardized annual data on abortion drug use, including prescribing numbers, deaths within 120 days, and serious complications. The bill directly affects providers who prescribe/administer abortion drugs, manufacturers, and federal agencies (FDA/CDC), aiming to improve data accuracy by addressing current underreporting gaps. Key changes include standardized data collection, public annual reports, and requiring providers to report even if patient details are excluded.